Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04124601
Title Neoadjuvant Chemoradiotherapy With Sequential Ipilimumab and Nivolumab in Rectal Cancer (CHINOREC)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Johannes Laengle, MD, PhD
Indications

rectum cancer

Therapies

Capecitabine

Capecitabine + Ipilimumab + Nivolumab

Age Groups: adult | senior
Covered Countries


No variant requirements are available.